Prof Andrew Coats and Prof Scott Solomon discuss the latest SGLT2's - guidelines, data and future practices. 

This interview is a component of a wider Radcliffe Education programme entitled 'Current and emerging data on SGLT" inhibitors in heart failure'.

Certified accreditation of the full programme is pending following application to the European Board for Accreditation in Cardiology (EBAC)

This video is partially funded by an unrestricted education grant from AstraZeneca.